接受门诊胃肠外抗菌治疗服务的患者的首剂抗菌药物输注反应
First-Dose Antimicrobial Infusion Reactions in Patients Enrolled in Outpatient Parenteral Antimicrobial Therapy Services.
作者信息
Kovacik Carrie N, Shah Megan D, Thomas Tania A, Eby Joshua C
机构信息
Department of Pharmacy, University of Virginia Health, Charlottesville, Virginia, USA.
Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health, Charlottesville, Virginia, USA.
出版信息
Open Forum Infect Dis. 2023 May 3;10(6):ofad239. doi: 10.1093/ofid/ofad239. eCollection 2023 Jun.
Abstract
After receiving a monitored first-dose antimicrobial infusion at an infusion center, 6 of 93 (6%) patients enrolled in outpatient parenteral antimicrobial therapy services experienced an immediate reaction, none of which were consistent with immunoglobulin E-mediated reactions. These findings suggest it would be reasonable to forgo monitoring for most patients receiving first-dose intravenous antimicrobials outpatient.
摘要
在输液中心接受首剂抗菌药物监测输液后，93名参加门诊胃肠外抗菌治疗服务的患者中有6名（6%）出现即刻反应，均与免疫球蛋白E介导的反应不符。这些发现表明，对于大多数门诊接受首剂静脉抗菌药物治疗的患者而言，放弃监测是合理的。
相似文献
1
First-Dose Antimicrobial Infusion Reactions in Patients Enrolled in Outpatient Parenteral Antimicrobial Therapy Services.
Open Forum Infect Dis. 2023 May 3;10(6):ofad239. doi: 10.1093/ofid/ofad239. eCollection 2023 Jun.
2
Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
PLoS Med. 2015 Dec 15;12(12):e1001922. doi: 10.1371/journal.pmed.1001922. eCollection 2015 Dec.
3
Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees.
J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):65-71. doi: 10.1093/jpids/piv106.
4
[The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
Kansenshogaku Zasshi. 2014 May;88(3):269-74. doi: 10.11150/kansenshogakuzasshi.88.269.
5
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
Int J Clin Pharm. 2022 Apr;44(2):557-563. doi: 10.1007/s11096-022-01379-7. Epub 2022 Feb 14.
6
Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Diabetes Metab Res Rev. 2015 Sep;31(6):638-45. doi: 10.1002/dmrr.2651. Epub 2015 May 19.
7
[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
Med Mal Infect. 2006 Mar;36(3):132-7. doi: 10.1016/j.medmal.2006.01.002. Epub 2006 Mar 31.
8
Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
J Pharm Pract. 2015 Oct;28(5):462-8. doi: 10.1177/0897190014544786. Epub 2014 Aug 8.
9
[Outpatient Parenteral Antimicrobial Therapy (OPAT) with Elastomeric Pumps in Collaboration with Home-visit Nursing Services in Japan: Experience of the First 10 Patients].
Kansenshogaku Zasshi. 2015 Sep;89(5):567-73. doi: 10.11150/kansenshogakuzasshi.89.567.
10
Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Clin Infect Dis. 2022 Nov 30;75(11):1921-1929. doi: 10.1093/cid/ciac298.
引用本文的文献
1
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.
本文引用的文献
1
Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Clin Infect Dis. 2022 Nov 30;75(11):1921-1929. doi: 10.1093/cid/ciac298.
2
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
3
2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.
Clin Infect Dis. 2019 Jan 1;68(1):e1-e35. doi: 10.1093/cid/ciy745.
4
A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
Infect Control Hosp Epidemiol. 2018 Aug;39(8):947-954. doi: 10.1017/ice.2018.107. Epub 2018 Jun 12.
5
Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.
Clin Infect Dis. 2018 Jan 6;66(1):11-19. doi: 10.1093/cid/cix733.
6
Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy.
J Pharm Pract. 2017 Dec;30(6):600-605. doi: 10.1177/0897190016688771. Epub 2017 Jan 23.
7
Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.
Open Forum Infect Dis. 2016 Oct 19;3(4):ofw193. doi: 10.1093/ofid/ofw193. eCollection 2016 Oct.
8
Antibiotic hypersensitivity reactions and approaches to desensitization.
Clin Infect Dis. 2014 Apr;58(8):1140-8. doi: 10.1093/cid/cit949. Epub 2013 Dec 23.
9
Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11.
10
Home intravenous antibiotic therapy and allergic drug reactions: is there a case for routine supply of anaphylaxis kits?
J Infus Nurs. 2004 Nov-Dec;27(6):425-30. doi: 10.1097/00129804-200411000-00008.
Zotero 插件